SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-24-056401
Filing Date
2024-05-02
Accepted
2024-05-02 16:16:04
Documents
1
Group Members
KOH, BONGSHAH, NIMISHVENROCK HEALTHCARE CAPITAL PARTNERS EG, L.P.VHCP CO-INVESTMENT HOLDINGS III, LLCVHCP MANAGEMENT EG, LLCVHCP MANAGEMENT III, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2413333d1_sc13g.htm SC 13G 177911
  Complete submission text file 0001104659-24-056401.txt   179859
Mailing Address 530 FIFTH AVENUE, 22ND FLOOR NEW YORK NY 10036
Business Address 530 FIFTH AVENUE, 22ND FLOOR NEW YORK NY 10036 212-444-4100
Venrock Healthcare Capital Partners III, L.P. (Filed by) CIK: 0001738048 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Subject) CIK: 0001855644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92696 | Film No.: 24908511
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)